Identification of a multi-tissue transcriptional signature of CR in mice. by Jamie L. Barger (246202)

Decoy Wnt receptor sLRP6E1E2 decreases proliferation in human lung cancer cells. by Jung-Sun Lee (164985)

LPC-DHA inhibits Srebp activity and de novo lipogenesis and Mfsd2a is regulated by Srebp. by Jia Pei Chan (5593388)

“…Scd1 expression in NSC^WT cells decreased with LPC-DHA treatment, but to a lesser extent in NSC^KO cells. β-actin served as a loading control. …”

Illustration of vaccine propensity. by Bert Baumgaertner (3595814)

Decreasing HIV transmissions to African American women through interventions for men living with HIV post-incarceration: An agent-based modeling study by Joëlla W. Adams (2192254)

“…Interventions optimizing HIV care engagement and minimizing sexual risk behaviors for men living with HIV post-incarceration may decrease HIV incidence.</p><p>Methods</p><p>Using an agent-based model, we simulated a sexual and injection drug using network representing the African American population of Philadelphia. …”

Silencing class II PI3Ks decreases autophagy in both control and <i>Vps34</i> null MEFs. by Kelly Devereaux (466106)

Statins differentially alter NSPC fate through a non-CBP dependent mechanism. by Ross A. Carson (5184512)

Pravastatin induces CBP gene expression in NSPCs. by Ross A. Carson (5184512)

Statins alter mRNA expression in differentiating NSPCs through a non-CBP dependent mechanism. by Ross A. Carson (5184512)

Fig 2 - by Rafael Alves Guimarães (4526788)

Pravastatin increases cyclin D1 expression but prevents passage through S-Phase in NSPCs. by Ross A. Carson (5184512)

Pravastatin enhances cell death and reduces G1 accumulation of NSPCs. by Ross A. Carson (5184512)

DataSheet1_Oxidized low density lipoprotein in the liver causes decreased permeability of liver lymphatic- but not liver sinusoidal-endothelial cells via VEGFR-3 regulation of VE-C... by Alyssa R. Goldberg (13979865)

“…To determine if liver lymphatic function is impaired in chronic liver diseases, in which increased oxLDL has been documented, we measured liver lymphatic function in murine models of NAFLD, ALD and primary sclerosing cholangitis (PSC). We found that Mdr2−/− (PSC), Lieber-DeCarli ethanol fed (ALD) and high fat and high cholesterol diet fed (NAFLD) mice all had a significant impairment in the ability to traffic FITC labeled dextran from the liver parenchyma to the liver draining lymph nodes. …”

Glycogen phosphorylase knockdown decreases doubling time of MCF-7 and MCF-10A cells. by Megan A. Altemus (7405727)

“…<p>Glycogen phosphorylase knockdown decreases doubling time of MCF-7 and MCF-10A cells.…”

Traditional and Microwave-Assisted Solvothermal Synthesis and Surface Modification of Co₇ Brucite Disk Clusters and Their Magnetic Properties by Yan-Ling Zhou (2132134)

Subjects:

tuning. Percentage of clusters enriched for spatial annotations in networks predicted by GINI as a function of tuning parameter for data from development stage 9–10 and 13–16.... by Kriti Puniyani (469389)

“…Percentage of clusters enriched for spatial annotations in networks predicted by GINI as a function of tuning parameter for data from development stage 9–10 and 13–16. …”

Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population by Mariana Milano (2141014)

“…We could not properly analyze <i>IL17A</i> -692 C>T (rs8193036) and <i>IFNG</i> +874T>A due to genotypic inconsistencies and found no evidence of association for the <i>IL2</i>, <i>IL4</i>, <i>IL10</i> and <i>TNF</i> polymorphisms and PTB. …”

Multi-way sensitivity analysis on transmission rate, CD4 count at diagnosis, and ART costs in a model-based analysis of Immediate ART initiation in Côte d’Ivoire. by Eric N. Ouattara (6890174)

BC2059 inhibits the binding of β-catenin to TBL-1 resulting in decreased β-catenin activity. by Danielle Almeida Braggio (13961252)

Study selection criteria. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”